ABSTRACT
Omega-3 fatty acids play a role as adjuvants to drug therapy. In addition, a number of intervention studies have been carried out in patients with lupus erythematosus, atopy, asthma, Raynaud’s disease, and multiple sclerosis, which are only mentioned since the information about the effects of omega-3 fatty acids on these diseases are preliminary. The provision of a low saturated fat diet with increased amounts of omega-3 fatty acids should be beneficial in the prevention of coronary heart disease. Omega-3 fatty acids in the form of corn oil increased tumor formation, size, and number. The mice fed omega-3 fatty acids had fewer pulmonary metastasis, decreased serum estrogen, and prolactin concentration. Dietary control of saturated and polyunsaturated fatty acids during the control and intervention period, as well as differences in lifelong dietary intake of fatty acids must be carefully considered and differences in the ratio of omega-6/omega-3 noted.
